Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
INTELLIGENT BIO SOLUTIONS INC. (GBS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 10/04/2023 |
8-K
| Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other E...|
Docs:
|
"1,544,004 SHARES of Common Stock 5,728,723 Shares of Series E Convertible preferred stock 7,272,727 SERIES E Warrants AND 7,272,727 SERIES F Warrants of INTELLIGENT BIO SOLUTIONS INC. UNDERWRITING AGREEMENT October 2, 2023 Ladenburg Thalmann & Co. Inc. As the Representative of the Several underwriters, if any, named in Schedule I hereto 640 Fifth Avenue, 4th Floor 10019",
"Intelligent Bio Solutions Inc. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES E CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE delaware GENERAL CORPORATION LAW The undersigned, Spiro Sakiris, does hereby certify that: 1. He is the Chief Financial Officer of Intelligent Bio Solutions Inc., a Delaware corporation . 2. The Corporation is authorized to issue 10,000,000 shares of preferred stock, none of which are outstanding. 3. The following resolutions were duly adopted by the board of directors of the Corporation : WHEREAS, the certificate of incorporation of the Corporation provides for a class of its authorized stock known as preferred stock, consisting of 10,000,000 shares, $0.01 par value per share, issuable from time to time in one or more serie...",
"SERIES E COMMON STOCK PURCHASE WARRANT intelligent bio solutions INC. Warrant Shares: 8,363,636 Issue Date: October 4, 2023 CUSIP: 36151G147 ISIN: US36151G1470 THIS SERIES E COMMON STOCK PURCHASE WARRANT certifies that, for value received, CEDE & CO., or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date Shareholder Approval is received and effective and on or prior to 5:00 p.m. on the five-and-a-half year anniversary of the Issue Date but not thereafter, to subscribe for and purchase from Intelligent Bio Solutions Inc., a Delaware corporation , up to 8,363,636 shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Pri...",
"SERIES F COMMON STOCK PURCHASE WARRANT intelligent bio solutions INC. Warrant Shares: 8,363,636 Issue Date: October 4, 2023 CUSIP: 36151G154 ISIN: US36151G1546 THIS SERIES F COMMON STOCK PURCHASE WARRANT certifies that, for value received, CEDE & CO., or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date Shareholder Approval is received and effective and on or prior to 5:00 p.m. on the one-and-a-half year anniversary of the Issue Date but not thereafter, to subscribe for and purchase from Intelligent Bio Solutions Inc., a Delaware corporation , up to 8,363,636 shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Pric...",
"REPRESENTATIVE COMMON STOCK PURCHASE WARRANT intelligent bio solutions INC. Warrant Shares: Initial Exercise Date: October 4, 2023 THIS REPRESENTATIVE COMMON STOCK PURCHASE WARRANT certifies that, for value received, or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof and on or prior to 5:00 p.m. on October 2, 2028 but not thereafter, to subscribe for and purchase from Intelligent Bio Solutions Inc., a Delaware corporation , up to shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. This Warrant is issued pursuant to the Underwriting Agreement . Section 1 . Definitions . In ad...",
"Fees",
"Intelligent Bio Solutions Inc. Announces Pricing of $4,000,000 Underwritten Public Offering",
"Intelligent Bio Solutions Inc. Announces Closing of $4.378 Million Underwritten Public Offering Including Partial Exercise of Underwriters’ Overallotment Option" |
|
| 09/27/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 08/25/2023 |
8-K
| Quarterly results |
| 08/01/2023 |
8-K
| Quarterly results |
| 07/26/2023 |
8-K
| Quarterly results |
| 07/07/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 07/03/2023 |
8-K
| Quarterly results |
| 06/30/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 06/15/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/17/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...|
Docs:
|
"Convertible Loan Conversion Agreement This Convertible Loan Conversion Agreement , dated as of May 9, 2023, is made and entered into by and among Intelligent Fingerprinting Limited, a company registered in England and Wales with company number 06409298 , Intelligent Bio Solutions Inc. , a Delaware corporation , and [●] . The Borrower, the Guarantor and the Lender are each sometimes referred to herein individually as a “Party” and collectively as the “Parties.” Capitalized terms used herein and not otherwise defined herein shall have the meanings given to them in the Share Exchange Agreement or the Restated Facility Agreement , as applicable. RECITALS A. The Borrower and the Lender entered into a facility agreement dated October 26, 2021 pursuant to which the Lenders, among other thin..." |
|
| 05/17/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 05/12/2023 |
8-K
| Quarterly results |
| 05/12/2023 |
8-K
| Unregistered Sales of Equity Securities, Departure of Directors or Certain Officers; Election of Directors; Appointment of Ce... |
| 05/05/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 04/27/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 04/18/2023 |
8-K
| Quarterly results |
| 03/31/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 03/15/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 03/10/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...|
Docs:
|
"569,560 SHARES of Common Stock and 170,868 Warrants of INTELLIGENT BIO SOLUTIONS INC. UNDERWRITING AGREEMENT March 8, 2023 Ladenburg Thalmann & Co. Inc. As the Representative of the Several underwriters, if any, named in Schedule I hereto c/o Ladenburg Thalmann & Co. Inc. 640 Fifth Avenue, 4th Floor 10019",
"REPRESENTATIVE COMMON STOCK PURCHASE WARRANT intelligent bio solutions INC. Warrant Shares: _______ Initial Exercise Date: March 10, 2023 THIS REPRESENTATIVE COMMON STOCK PURCHASE WARRANT certifies that, for value received, _____________ or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof and on or prior to 5:00 p.m. on March 8, 2028 but not thereafter, to subscribe for and purchase from Intelligent Bio Solutions Inc., a Delaware corporation , up to ______ shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. This Warrant is issued pursuant to the Underwriting Agreement . Secti...",
"COMMON STOCK PURCHASE WARRANT intelligent bio solutions INC. Warrant Shares: _______ Initial Exercise Date: March 10, 2023 THIS COMMON STOCK PURCHASE WARRANT certifies that, for value received, _____________ or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof and on or prior to 5:00 p.m. on March 10, 2028 but not thereafter, to subscribe for and purchase from Intelligent Bio Solutions Inc., a Delaware corporation , up to ______ shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. This Warrant shall initially be issued and maintained in the form of a security held in book-entry...",
"main",
"Annex A: Form of Warrant Certificate Request Notice WARRANT CERTIFICATE REQUEST NOTICE To: Continental Stock Transfer & Trust Company, as Warrant Agent for Intelligent Bio Solutions Inc. The undersigned Holder of Common Stock Purchase Warrants in the form of Global Warrants issued by the Company hereby elects to receive a Warrant Certificate evidencing the Warrants held by the Holder as specified below: 1. Name of Holder of Warrants in form of Global Warrants: ___________________________ 2. Name of Holder in Warrant Certificate : ________________________________ 3. Number of Warrants in name of Holder in form of Global Warrants: ___________________ 4. Number of Warrants for which Warrant Certificate shall be issued: __________________ 5. Number of Warrants in name of Holder in form of Glob...",
"Intelligent Bio Solutions Inc. Announces Proposed Public Offering",
"Intelligent Bio Solutions Inc. Announces Pricing of $2.2 Million Public Offering",
"Intelligent Bio Solutions Inc. Announces Closing of $2.55 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares and Warrants" |
|
| 03/02/2023 |
8-K/A
| Financial Statements and Exhibits Interactive Data |
| 03/02/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 02/09/2023 |
8-K
| Material Modifications to Rights of Security Holders, Departure of Directors or Certain Officers; Election of Directors; Appo... |
| 02/08/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 02/01/2023 |
8-K
| Quarterly results |
| 01/27/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 12/22/2022 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu...|
Docs:
|
"INTELLIGENT BIO SOLUTIONS INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF",
"INTELLIGENT BIO SOLUTIONS INC. COMMON STOCK PURCHASE WARRANT Warrant Shares: [___________] Initial Exercise Date: June 22, 2023 Issue Date: December 22, 2022 THIS COMMON STOCK PURCHASE WARRANT certifies that, for value received, [_________] or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after June 22, 2023 and on or prior to 5:00 p.m. on June 22, 2028 provided, however, if such date is not a Trading Day, the immediately following Trading Day but not thereafter, to subscribe for and purchase from Intelligent Bio Solutions Inc., a Delaware corporation , up to [_________] shares of common stock of the Company, par value $0.01 per share . The purchase price of one share of Common Stock under this...",
"INTELLIGENT BIO SOLUTIONS INC. COMMON STOCK PURCHASE WARRANT Warrant Shares: 26,469 Initial Exercise Date: June 22, 2023 Issue Date: December 22, 2022 THIS COMMON STOCK PURCHASE WARRANT certifies that, for value received, Winx Capital Pty Ltd. or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after June 22, 2023 and on or prior to 5:00 p.m. on the date that is the 5 year anniversary of the effective date of the Registration Statement; provided, however, if such date is not a Trading Day, the immediately following Trading Day but not thereafter, to subscribe for and purchase from Intelligent Bio Solutions Inc., a Delaware corporation , up to 26,469 shares of common stock of the Company, par value...",
"Annex A Regulation S Supplement Definitions Capitalized terms that are not otherwise defined herein have the meanings given to such terms in the Securities Purchase Agreement is dated as of December 21, 2022, between Intelligent Bio Solutions Inc., a Delaware corporation , and each purchaser identified on the signature pages thereto. Additional Representations and Warranties of Purchaser",
"REGISTRATION RIGHTS AGREEMENT BY AND BETWEEN INTELLIGENT BIO SOLUTIONS INC. THE SELLERS LISTED ON ANNEX A HERETO Dated as of December 21, 2022",
"Intelligent Bio Solutions Inc. Announces Closing of Private Placement Offering" |
|
| 12/21/2022 |
8-K
| Quarterly results |
| 12/14/2022 |
8-K
| Quarterly results |
| 12/08/2022 |
8-K/A
| Quarterly results |
| 11/09/2022 |
8-K
| Quarterly results |
| 10/27/2022 |
8-K
| Quarterly results |
| 10/11/2022 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financia...|
Docs:
|
"JASON ISENBERG, AS THE RFA SELLERS’ REPRESENTATIVE AND PHILIP HAND, AS THE OTHER SELLERS’ REPRESENTATIVE Dated as of October 4, 2022",
"GBS INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES C CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW The undersigned, Spiro Sakiris, does hereby certify that: 1. He is the Chief Financial Officer of GBS Inc., a Delaware corporation whose registered office is at 142 West 57 th Street, 11 th Floor, 10019, USA. 2. The Corporation is authorized to issue 10,000,000 shares of preferred stock. 3. The following resolutions were duly adopted by the board of directors of the Corporation : WHEREAS, the certificate of incorporation of the Corporation provides for a class of its authorized stock known as preferred stock, consisting of 10,000,000 shares, $0.01 par value per share, issuable from time to time in one or more seri...",
"Schedule 2 Company Appointees 1. Dr. Steven Boyages 2. Lawrence Fisher 3. Johnathan S. Hurd 4. Dr. George Magelis 5. Christopher Towers Schedule 3 RFA Appointees",
"REGISTRATION RIGHTS AGREEMENT",
"REGISTRATION RIGHTS AGREEMENT",
"Voting Agreement This Voting Agreement , dated as of October 4, 2022, is made and entered into by and between the stockholders listed on Exhibit A hereto of GBS Inc., a Delaware corporation , and the Company. The Stockholders and the Company are each sometimes referred to herein individually as a “ Party ” and collectively as the “ Parties .” RECITALS A. Concurrently with the execution of this Agreement, the Company, the Stockholders, Intelligent Fingerprinting Limited, a company registered in England and Wales with company number 06409298 , Sellers and Sellers’ Representatives, are entering into a Share Exchange Agreement , pursuant to which, among other things, Sellers are selling all of the issued shares in the capital of IFP to the Company, and the Company is issuing shares of common s...",
"Voting Agreement This Voting Agreement , dated as of October 4, 2022, is made and entered into by and among the undersigned stockholder who is also a director and/or officer of GBS Inc., a Delaware corporation , the Company, Jason Isenberg, as the RFA Sellers’ Representative , and Philip Hand, as the Other Sellers’ Representative as such term is defined in the Share Exchange Agreement referenced below). Stockholder, the Company and Sellers’ Representatives are each sometimes referred to herein individually as a “ Party ” and collectively as the “ Parties .” RECITALS A. Concurrently with the execution of this Agreement, the Company, Intelligent Fingerprinting Limited, a company registered in England and Wales with company number 06409298 , Sellers and Sellers’ Representatives, are entering ...",
"Extension Agreement, to Bridge Facility Agreement, between the Company and Intelligent Fingerprinting Limited",
"DATED deed of amendment and restatement between Intelligent Fingerprinting Limited Karin Briden and GBS, Inc. relating to BRIDGE FACILITY AGREEMENT dated 26 October 2021 CONTENTS CLAUSE 1. Definitions and interpretation ii 2. Restatement of the Original Facility Agreement iii 3. Existing security iii 4. Continuity and further assurance iii 5. Miscellaneous iv 6. Third party rights iv 7. Governing law and jurisdiction iv SCHEDULE",
"DATED deed of amendment and restatement between Intelligent Fingerprinting Limited Debra Coffey and GBS, Inc. relating to BRIDGE FACILITY AGREEMENT dated 26 October 2021 CONTENTS CLAUSE 1. Definitions and interpretation ii 2. Restatement of the Original Facility Agreement iii 3. Existing security iii 4. Continuity and further assurance iii 5. Miscellaneous iv 6. Third party rights iv 7. Governing law and jurisdiction iv SCHEDULE Schedule 1 Form of amended and restated facility agreement v This deed is dated October 4, 2022 Parties INTELLIGENT FINGERPRINTING LIMITED, a company incorporated in England and Wales whose registered office is at 14-17 Evolution Business Park Milton Road, Impington, Cambridge, CB24 9NG ; Debra Coffey of 500 Throckmorton Street No. 2204 Fort Worth Texas 76102 Unite..." |
|
| 09/29/2022 |
8-K
| Quarterly results |
|
|
|